Pharmasset (VRUS) Jumps On Bullish Analyst Comments
Tweet
Share
E-mailGet Alerts VRUS Hot Sheet
Price: $0.00 --0%
Rating Summary:
3 Buy, 10 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 7 | New: 6
Rating Summary:
3 Buy, 10 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 7 | New: 6
Join SI Premium – FREE
Pharmasset, Inc. (Nasdaq: VRUS) is jumping higher in early trade after analysts at Morgan Stanley made bullish comments on the stock and issued a bull case price target of $341.
Shares are up 4%.
Shares are up 4%.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Wells Fargo Starts X4 Pharmaceuticals (XFOR) at Overweight
- Procter & Gamble (PG) PT Lowered to $166 at BofA Securities
- BRT Apartments (BRT) PT Lowered to $18.50 at B.Riley
Create E-mail Alert Related Categories
Analyst Comments, Hot CommentsRelated Entities
Morgan StanleySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
